UBS Group’s Tevogen Inc TVGN Stock Holding History

UBS Group’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.13K	Sell	1,083 -2,484	-70%	-$19.8K	﹤0.01%	8860
2026 Q1	$16.1K	Buy	3,567 +2,469	+225%	+$30.3K	﹤0.01%	8084
2025 Q4	$18.2K	Buy	1,098 +280	+34%	+$7.28K	﹤0.01%	7855
2025 Q3	$32.1K	Sell	818 -804	-50%	-$39.5K	﹤0.01%	7849
2025 Q2	$101K	Sell	1,622 -2,055	-56%	-$117K	﹤0.01%	7228
2025 Q1	$199K	Sell	3,677 -15	-0.4%	-$987	﹤0.01%	6567
2024 Q4	$190K	Buy	3,692 +3,480	+1,642%	+$227K	﹤0.01%	6479
2024 Q3	$3.89K	Buy	212 +79	+59%	+$2.31K	﹤0.01%	8206
2024 Q2	$4.8K	Buy	+133	New	+$8.67K	﹤0.01%	8050
2023 Q4	–	Sell	-3	Closed	-$1.59K	–	9978
2023 Q3	$1.59K	Buy	+3	New	+$1.62K	﹤0.01%	7885
2023 Q2	–	Sell	-14	Closed	-$7.76K	–	9779
2023 Q1	$7.76K	Buy	14 +12	+600%	+$6.37K	﹤0.01%	7778
2022 Q4	$1.03K	Sell	2 -2	-50%	-$1.02K	﹤0.01%	9982
2022 Q3	$2K	Hold	4	–	–	﹤0.01%	9792
2022 Q2	$2K	Buy	+4	New	+$2K	﹤0.01%	9634

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group's TVGN Position: Q2 2026 in Review

UBS Group reduced its Tevogen Inc (TVGN) stake by 70% in Q2 2026, selling an estimated $19.8K and leaving 1,083 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #8860.

UBS Group first reported a position in TVGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $199K in Q1 2025. 31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

UBS Group held 1,083 shares of Tevogen Inc worth $6.13K as of Q2 2026.
UBS Group sold 2,484 Tevogen Inc shares in Q2 2026, an estimated $19.8K.
Tevogen Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8860 holding.
UBS Group first reported a position in Tevogen Inc in Q2 2022 and has held it in 14 quarters since.
UBS Group's Tevogen Inc position peaked at $199K in Q1 2025.
31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.